Drug Shortage Report for FORTAZ

Last updated on 2020-12-22 History
Report ID 51027
Drug Identification Number 02212218
Brand name FORTAZ - INJ 1G/VIAL
Common or Proper name Ceftazidime for injection
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFTAZIDIME
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10's
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2018-05-31
Estimated end date
Actual end date 2020-12-21
Shortage status Resolved
Updated date 2020-12-22
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-12-22 French Compare
v16 2020-12-22 English Compare
v15 2020-02-27 French Compare
v14 2020-02-27 English Compare
v13 2019-10-18 French Compare
v12 2019-10-18 English Compare
v11 2019-07-10 French Compare
v10 2019-07-10 English Compare
v9 2019-04-10 French Compare
v8 2019-04-10 English Compare
v7 2018-12-03 French Compare
v6 2018-12-03 English Compare
v5 2018-10-03 French Compare
v4 2018-10-03 English Compare
v3 2018-06-01 English Compare
v2 2018-05-31 French Compare
v1 2018-05-31 English Compare

Showing 1 to 17 of 17